XML 81 R69.htm IDEA: XBRL DOCUMENT v3.20.2
Investments in Unconsolidated VIEs (Details) - Variable Interest Entity, Not Primary Beneficiary - Navitor Pharmaceuticals, Inc. - USD ($)
$ in Millions
1 Months Ended
Apr. 30, 2020
Sep. 30, 2020
Variable Interest Entity [Line Items]    
Agreement termination notice period 30 days  
Threshold for development costs payments $ 50  
Payment for option issue fee 10  
Investments $ 15 $ 15
VIE, qualitative or quantitative information, ownership percentage 13.00%